USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Enabling faster analysis using advanced tools
31-Aug-2020
Technology Research
D9B1-01-00-00-00
HC03334-GL-TR_24701
Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through large volumes of data and provide accurate results within minutes which takes enormous time when performed by humans. Application of analytical tools help identify trends and patterns that may have been difficult to observe otherwise and provide results in the best possible way.
The Strategic Imperative 8™
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Data Science Industry
About The Growth Pipeline Engine™
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Key Findings
1.1 Clinical Trials Still the most Complex Step in the Lifecycle of Drug Development
1.2 Following Conventional Steps in Clinical Trials is an Ongoing Challenge
1.3 Importance of Data Science in Clinical Trials
1.4 Important Terminologies Associated with Data Science and its Role
2.1 Adoption of Data Science in Clinical Trials is Seen across the Globe
2.2 Key Factors to Leverage Use of Data Science in Clinical Trials
2.3 NLP and OCR are Extensively Used in Data Structuring
2.4 Data Science Taps Untapped Significant Information
2.5 Data science Tools Help Reduce Clinical Trial Timeline
2.6 Downstream Workflow of Data Science Tools
2.7 Medical Data Conversion to E health Data is an Essential Step
3.1 AI Based Models Provide Predictive Solutions
3.2 Data Driven Models’ Focus Areas
3.3 Key Challenges in Patient Enrollment
3.4 Use of Digital Platforms Increases Patient Retention
3.5 Role of Data Science in Leveraging Cancer Treatments
3.6 Role of Data Science in the Rare Disease Area
3.7 Enabling Virtual Clinical Trials Using Data Science during COVID-19
3.8 AI Tools Speed up Patient Recruitment
3.9 Data Sharing to be Driving Factor in AI Enabled Clinical Trials
4.1 Collaboration between Big Pharma and AI Companies to Leverage Clinical Trials
4.2 Tech Companies Come together to Pool Resources
4.3 Mendel.ai
4.4 Ai Cure
4.5 Inato
4.6 GNS Healthcare
4.7 Trials.ai
4.8 Antidote
4.9 Deep 6 Ai
4.10 BullFrog Ai
4.11 PathAI
4.12 Tempus
5.1 IP Overview of Data Science in Pharmaceutical Development
5.2 Top Patent List
5.3 Top Patents in Screening Patients Technology
5.4 Top Patents in Structured Platforms
6.1 Growth opportunity 1: Data Science driven Patient Selection
6.1 Growth Opportunity 1: Data Science-driven Patient Selection
6.2 Growth opportunity 2: FDA accelerated Data sharing has opened many opportunities
6.2 Growth Opportunity 2: FDA accelerated sharing has opened many opportunities (continued)
Abbreviation
Key Industry Contacts
YOUR NEXT STEPS
WHY FROST, WHY NOW?
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Neeraja Vettekudath |
| Industries | Healthcare |
| WIP Number | D9B1-01-00-00-00 |
| Is Prebook | No |
Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications
$4,950.00
Special Price $3,712.50 save 25 %